The FDA and some oncologists have resisted efforts to require a quick, cheap gene test that could prevent thousands of deaths from a bad reaction to a common cancer drug.
A state policy to extend Medi-Cal to qualified Californians without legal residency is running up against a federal requirement to resume eligibility checks. The redetermination process is causing many Latinos, who make up a majority of Medi-Cal beneficiaries, to be disenrolled.
The Environmental Protection Agency is tightening regulation of ethylene oxide, a carcinogenic gas used to sterilize medical devices. The agency is trying to balance the interests of the health care industry supply chain with those of communities where the gas creates airborne health risks.
After a decade of work, a Kentucky program launched to diagnose lung cancer earlier is beginning to change the prognosis for residents by catching tumors when they’re more treatable.
The FDA’s recent notice that it would move to ban formaldehyde in hair-straightening products comes more than a decade after researchers raised alarms about health risks. Scientists say a ban would still leave many dangerous chemicals in hair straighteners.
Artificial intelligence software to aid radiologists in detecting problems or diagnosing cancer has been moving rapidly into clinical use, where it shows great promise. But it’s a turnoff for some patients asked to pay out-of-pocket for technology that’s not quite ready for prime time.
The popular actress and author, who died this week, also can be remembered as a progenitor of selling dubious medical information to a trusting public.
A breast cancer patient who received similar treatments in two states saw significant differences in cost, illuminating how care in remote areas can come with a stiffer price tag.
Federal research linking “forever chemicals” to testicular cancer confirms what U.S. military personnel long suspected. But as they seek testing for PFAS exposure, many wonder what to do with the results. There’s no medical treatment yet.
Mississippi has among the highest cervical cancer mortality rates in the U.S. When low-income women can’t afford regular preventive care, much less gynecological visits, this highly preventable and treatable cancer becomes a killer.